207_Combined course Presentations

MMC - Comparison 1 versus 2 doses

no difference

• PFS (HR 0.85, 95% CI 0.37–1.92), • CFS (HR 0.91, 95% CI 0.31–2.67) between the MMC1 and MMC2 groups. • Acute grade ⩾ 2 toxicities were worse in the MMC2 group. • 3 treatment-related deaths, all in the MMC2 group

• White et al Chemoradiotherapy for squamous cell carcinoma of the anal canal: Comparison of one versus two cycles mitomycin-C. Radiother Oncol 2015;117 (2):240–245